These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2008-006421-13 Multicenter Phase II Study: Bendamustine plus Bortezomib plus Dexamethasone in the treatment of stage II/III relapsed or refractory multiple myeloma 2013-12-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-006497-15 Lenalidomide and Dexamethasone for treatment of patients with acute myeloma (light chain)-induced renal failure 2014-09-15 bad-data